AstraZeneca PLC (AZN.L) LSE

13,654.00

+140(+1.04%)

Updated at December 05 10:54AM

Currency In GBp

Valuation

Market Cap203B
Enterprise Value227.63B
P/E Ratio33.1
PEG Ratio4.54
Price/Sales Ratio4.88
Price/Book Ratio6.25
Enterprise/Revenue5.33
Enterprise/EBITDA16.22

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.15
Operating Margin0.21

Management Effectiveness

Return On Assets0.08
Return On Equity0.2

Income Statement

Revenue52.94B
Revenue/Share36.97
Gross Profit39.7B
EBITDA14.86B
Net Income6.89B
Diluted EPS4.41

Balance Sheet

Total Cash8.18B
Total Cash/Share4.59
Total Debt32.66B
Total Debt/Equity0.73
Current Ratio0.86
Book Value Per Share28.91

Price History

52-Week Change27.27
52-Week High14,206
52-Week Low9,573.5
Moving Average 50 Days12,881.72
Moving Average 200 Days11,453.1

Statistics

Average Volume2.07M
Shares Outstanding1.55B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate2.8
Trailing Annual Dividend Yield1.55
Payout Ratio0.58
Last Split FactorN/A
Last Split DateN/A